Regulus Therapeutics
RGLS
#7202
Rank
HK$4.42 B
Marketcap
HK$63.96
Share price
0.00%
Change (1 day)
440.42%
Change (1 year)

EPS for Regulus Therapeutics (RGLS)

EPS in 2025 (TTM): -HK$5.68

According to Regulus Therapeutics's latest financial reports the company's current EPS (TTM) is -HK$5.72. In 2024 the company made an earnings per share (EPS) of -HK$6.82.

EPS history for Regulus Therapeutics from 2013 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$5.68-16.71%
2024-HK$6.82
2022-HK$14.58-43.12%
2021-HK$25.63-40.55%
2020-HK$43.11-50%
2019-HK$86.22-80.36%
2018-HK$438.94-57.8%
2017-HK$1,040-28.66%
2016-HK$1,45842.2%
2015-HK$1,025-14.84%
2014-HK$1,204156%
2013-HK$470.29

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
HK$15.52-371.31%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
HK$18.50-423.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$35.43-719.18%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$55.81-1,075.34%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
HK$22.55-494.16%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sangamo Therapeutics
SGMO
-HK$2.98-47.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
HK$155.27-2,813.70%๐Ÿ‡บ๐Ÿ‡ธ USA